129 related articles for article (PubMed ID: 37832810)
1. Huaier suppresses cisplatin resistance in non-small cell lung cancer by inhibiting the JNK/JUN/IL-8 signaling pathway.
Jin H; Liu C; Liu X; Wang H; Zhang Y; Liu Y; Li J; Yu Z; Liu HX
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117270. PubMed ID: 37832810
[TBL] [Abstract][Full Text] [Related]
2. An extraction from Trametes robiniophila Murr. (
Lv F; Li X; Wang Y
Bioengineered; 2022 Apr; 13(4):10931-10943. PubMed ID: 35470770
[TBL] [Abstract][Full Text] [Related]
3. Huaier aqueous extract sensitizes cells to rapamycin and cisplatin through activating mTOR signaling.
Hu Z; Yang A; Fan H; Wang Y; Zhao Y; Zha X; Zhang H; Tu P
J Ethnopharmacol; 2016 Jun; 186():143-150. PubMed ID: 27045863
[TBL] [Abstract][Full Text] [Related]
4. Huaier extract suppresses non-small cell lung cancer progression through activating NLRP3-dependent pyroptosis.
Xie J; Zhuan B; Wang H; Wang Y; Wang X; Yuan Q; Yang Z
Anat Rec (Hoboken); 2021 Feb; 304(2):291-301. PubMed ID: 31692261
[TBL] [Abstract][Full Text] [Related]
5. CHD1L contributes to cisplatin resistance by upregulating the ABCB1-NF-κB axis in human non-small-cell lung cancer.
Li Y; He LR; Gao Y; Zhou NN; Liu Y; Zhou XK; Liu JF; Guan XY; Ma NF; Xie D
Cell Death Dis; 2019 Feb; 10(2):99. PubMed ID: 30718500
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer.
Xiao L; Lan X; Shi X; Zhao K; Wang D; Wang X; Li F; Huang H; Liu J
Cell Death Dis; 2017 May; 8(5):e2803. PubMed ID: 28518145
[TBL] [Abstract][Full Text] [Related]
7. Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLC.
Ryan SL; Beard S; Barr MP; Umezawa K; Heavey S; Godwin P; Gray SG; Cormican D; Finn SP; Gately KA; Davies AM; Thompson EW; Richard DJ; O'Byrne KJ; Adams MN; Baird AM
Lung Cancer; 2019 Sep; 135():217-227. PubMed ID: 31446998
[TBL] [Abstract][Full Text] [Related]
8. Huaier aqueous extract inhibits ovarian cancer cell motility via the AKT/GSK3β/β-catenin pathway.
Yan X; Lyu T; Jia N; Yu Y; Hua K; Feng W
PLoS One; 2013; 8(5):e63731. PubMed ID: 23667667
[TBL] [Abstract][Full Text] [Related]
9. Pentraxin 3 acts as a functional effector of Akt/NF-κB signaling to modulate the progression and cisplatin-resistance in non-small cell lung cancer.
Li Y; Song X; Niu J; Ren M; Tang G; Sun Z; Kong F
Arch Biochem Biophys; 2021 Apr; 701():108818. PubMed ID: 33617838
[TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenic and antitumor activities of Huaier aqueous extract.
Wang X; Zhang N; Huo Q; Yang Q
Oncol Rep; 2012 Oct; 28(4):1167-75. PubMed ID: 22895629
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin treatment increases stemness through upregulation of hypoxia-inducible factors by interleukin-6 in non-small cell lung cancer.
Zhang F; Duan S; Tsai Y; Keng PC; Chen Y; Lee SO; Chen Y
Cancer Sci; 2016 Jun; 107(6):746-54. PubMed ID: 27009878
[TBL] [Abstract][Full Text] [Related]
12. Functional cooperation between HIF-1α and c-Jun in mediating primary and acquired resistance to gefitinib in NSCLC cells with activating mutation of EGFR.
Meng S; Wang G; Lu Y; Fan Z
Lung Cancer; 2018 Jul; 121():82-90. PubMed ID: 29858032
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
Gong T; Cui L; Wang H; Wang H; Han N
J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
[TBL] [Abstract][Full Text] [Related]
14. An immune-stimulating proteoglycan from the medicinal mushroom Huaier up-regulates NF-κB and MAPK signaling via Toll-like receptor 4.
Yang A; Fan H; Zhao Y; Chen X; Zhu Z; Zha X; Zhao Y; Chai X; Li J; Tu P; Hu Z
J Biol Chem; 2019 Feb; 294(8):2628-2641. PubMed ID: 30602571
[No Abstract] [Full Text] [Related]
15. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
[TBL] [Abstract][Full Text] [Related]
16. PDIA6 modulates apoptosis and autophagy of non-small cell lung cancer cells via the MAP4K1/JNK signaling pathway.
Bai Y; Liu X; Qi X; Liu X; Peng F; Li H; Fu H; Pei S; Chen L; Chi X; Zhang L; Zhu X; Song Y; Wang Y; Meng S; Jiang T; Shao S
EBioMedicine; 2019 Apr; 42():311-325. PubMed ID: 30922965
[TBL] [Abstract][Full Text] [Related]
17. Proteasome inhibitor PS-341 induces growth arrest and apoptosis of non-small cell lung cancer cells via the JNK/c-Jun/AP-1 signaling.
Yang Y; Ikezoe T; Saito T; Kobayashi M; Koeffler HP; Taguchi H
Cancer Sci; 2004 Feb; 95(2):176-80. PubMed ID: 14965369
[TBL] [Abstract][Full Text] [Related]
18. Immunoregulatory effects of Huaier (Trametes robiniophila Murr) and relevant clinical applications.
Long H; Wu Z
Front Immunol; 2023; 14():1147098. PubMed ID: 37449208
[TBL] [Abstract][Full Text] [Related]
19. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling.
Wang HJ; Yang ZX; Dai XT; Chen YF; Yang HP; Zhou XD
Apoptosis; 2017 Sep; 22(9):1157-1168. PubMed ID: 28677094
[TBL] [Abstract][Full Text] [Related]
20. ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a/IRF-2 signaling pathway.
Xiao XH; He SY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3130-3142. PubMed ID: 32271431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
